Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
Viatris · Product launch · October 16, 2026
The U.S. Food and Drug Administration approved RYZUMVI, a phentolamine ophthalmic solution, for treating presbyopia in adults.
AntSpace’s summary of Viatris’s own announcement: read the original.